Analytical Data
-
Gene name
gp15
-
简介
Gp15 protein, part of the inner core during viral capsid formation, aids in ejecting viral DNA into the host cell. It forms a complex with gp16 and binds to both viral DNA and the host inner membrane. Gp15 interacts with gp14 and likely remains associated with gp16, controlling the translocation of DNA into the cell. gp15 Protein, Escherichia phage T7 (His, Strep) is the recombinant gp15 protein, expressed by E. coli , with N-Strep, N-6*His labeled tag.
- Application
-
Alternative Names
Internal virion protein gp15; Gene product 15; Gp15
-
Species
Others
-
Source
E. coli
-
Tag
N-StrepⅡ;N-6*His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P03725
-
Expression Region
S2-E747
-
Protein Length
Partial
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GP15 recombinant protein, derived from virus or bacterium, has garnered significant attention in biomedical research due to its potential applications in vaccine development and therapeutic interventions. The protein is implicated in immune response modulation, serving as an important target for the design of vaccines aimed at infectious diseases. Research has indicated that GP15 plays a crucial role in the pathogen's lifecycle and immune evasion strategies, making it a vital subject of interest for understanding pathogen-host interactions. The recombinant expression of GP15 allows for detailed structural and functional studies, enabling scientists to explore its mechanisms of action at a molecular level. Recent studies have focused on optimizing its expression and purification processes, as well as evaluating its immunogenicity and efficacy in preclinical models. The insights gained from these investigations could pave the way for novel vaccine candidates or therapeutic agents, contributing to global health initiatives against diseases where GP15 is involved. Overall, the research surrounding GP15 recombinant protein not only aims to unravel fundamental biological processes but also holds promise for translating findings into practical healthcare solutions.
